Navigation Links
Partnership Brings Breast Image Documentation Technology to Women Around the World

LOS ANGELES, July 13 /PRNewswire/ -- Medical Tactile, Inc. and Valentus Medical Technologies, Inc. announced today that Valentus Medical Technologies, Inc., based in Victoria, Canada, has signed a partnership agreement with Medical Tactile, Inc., and has taken on the exclusive Sales & Marketing rights for SureTouch™, the non-invasive digital breast imaging technology, worldwide, with the exception of China.

"Valentus has made a significant investment in Medical Tactile that will greatly assist us in advancing research and development for this important technology," said Jae Son, Chairman of Medical Tactile, Inc.  "Valentus brings a health and wellness clinic-based approach to help bring SureTouch™ to market in North America as well as grow existing international markets."

"We are excited about the partnership with MTI and are thrilled to be able to bring SureTouch™ technology to women of all ages around the world," said Stephen L. Davis, CEO of Valentus Medical Technologies, Inc.  "Nearly 45,000 women in North America alone will die from breast cancer in 2010, and the incidence of breast cancer in some developing countries is rising at a rate of up to 5% per year.  When breast cancer is found and treated early, when it is small, chances are better that it can be successfully removed and mortality can be reduced.  We believe that women deserve to have access to SureTouch™ technology and we hope to contribute to saving more lives by enhancing the Clinical Breast Exam (CBE) procedure with the improved documentation SureTouch™ technology provides."

SureTouch™ has FDA clearance and enhances the routine Clinical Breast Exam using Tactile or Palpation Imaging technology.  It is an accurate, non-invasive (uses no radiation), comfortable, and affordable breast image documentation device.  It measures the reactive pressures generated by a breast lesion, which can be as much as 100 times harder than normal tissue and may prove to be cancerous. It documents the shape, location, hardness and size of breast lesions. SureTouch™ is compact, portable and easy to set up. Training for physicians and other clinicians will be offered online.

About Valentus Medical Technologies, Inc.

Valentus Medical Technologies, Inc. (VMT) is a Victoria, Canada based provider of accurate, affordable, approved and easy to use medical devices that enhance the integrity of diagnosis and provide low cost accessibility to patients in order to improve their personal health and well-being.  VMT is owned and operated by Valentus Health Clinics, Inc., a leading health service practitioner, committed to improving people's health through the use of innovative, proven and non-invasive technologies.

About Medical Tactile, Inc.

Medical Tactile, Inc., is a leading developer of tactile sensor technologies for the detection and assessment of cancer and other diseases of the breast.  Medical Tactile's mission is to improve the quality and cost-effectiveness of healthcare services in this area.

SOURCE Valentus Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
3. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
4. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
5. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
8. iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix
9. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
10. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
11. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
Post Your Comments:
(Date:11/30/2015)... TOKYO , 1 décembre 2015 ... plus grande exposition et conférence d,Asie ... médicaux et sur l,industrie manufacturière, se ... du 20 au 22 avril ... - Photo - ...
(Date:11/30/2015)... Die MEDTEC Japan 2016, ... Entwicklung und Herstellung medizinischer Geräte, findet ... in Tokyo ... Foto: ... --> ...
(Date:11/30/2015)... 30, 2015 MEDTEC Japan 2016, Asia,s largest ... to be held in Tokyo from 20 th  - 22 nd April 2016. ... -->   --> --> ... the United States . With the aging population and the government back ... steadily. --> the United States . With the aging ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... annual fundraising campaign to raise funds for its research, education, support, and advocacy ... the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes ...
(Date:11/30/2015)... ... , ... According to Los Angeles bariatric surgeon Michael Feiz, M.D., F.A.C.S., many ... real hunger, but instead by a hormone called ghrelin which (often prematurely) signals ... are aware that weight loss surgery can help patients lose weight by restricting the ...
(Date:11/30/2015)... PA (PRWEB) , ... November 30, 2015 , ... A ... 15th annual Regional Biotech Conference, organized by the Baruch S. Blumberg Institute. , The ... 100 of the area’s life science and biotechnology leaders for the conference, which focused ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus ... State University. , Their study showed that small molecule analogs that target the ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... for innovative, patient centered orthopedic care. Led by John Vitolo, M.D., the ... or chronic condition, the team at Advocare Orthopedic & Sports Medicine is ready ...
Breaking Medicine News(10 mins):